Michel Clanet

Defining the clinical course of multiple sclerosis

Fred Lublin, Stephen C. Reingold, Jeffrey A. Cohen et al. · Neurology · 2014 · 3K citations · Full text

Neuroimaging Biomarkers, Scleroderma, Neurological Disease +15

Natural History of Multiple Sclerosis with Childhood Onset

Christel Renoux, Sandra Vukusic, Yann Mikaeloff et al. · New England Journal of Medicine · 2007 · 585 citations · Full text

Mutations within the Programmed Cell Death 10 Gene Cause Cerebral Cavernous Malformations

Françoise Bergametti, Christian Denier, Pierre Labauge et al. · The American Journal of Human Genetics · 2004 · 444 citations · Full text

Neurology, Neuropathology, Medicine +2

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study

Ayman Tourbah, Christine Lebrun‐Frénay, Gilles Edan et al. · Multiple Sclerosis Journal · 2016 · 284 citations · Full text

Mutation of the <i>PDGFRB</i> gene as a cause of idiopathic basal ganglia calcification

Gaël Nicolas, Cyril Pottier, David Maltête et al. · Neurology · 2012 · 275 citations